-
The authors enrolled women desiring postpartum use of a levonorgestrel-releasing intrauterine system in a randomized trial to determine whether use of the device would be higher when insertion occurred immediately postpartum rather than delaying placement to the standard postpartum visit.
-
It has long been assumed that acetaminophen, the common analgesic agent, is relatively safe for people with known coronary artery disease, in contrast to NSAIDs and COX-2 inhibitors. But assumptions can be dangerous, and this small study suggests that acetaminophen use may have similar risks associated with it, specifically increases in blood pressure.
-
A murine model was employed to assess the effects of chronic stress on metastatic breast cancer spread. The researchers used a variety of tools to investigate the neuroendocrine, molecular, and cellular effects of chronic stress in this setting. Their findings suggest that chronic stress induces a significant increase in the extent of cancer spread through the activity of the sympathetic nervous system. The findings open numerous research questions yet to be answered, as well as great therapeutic possibilities.
-
Tiotropium for uncontrolled asthma, sibutramine pulled from market, incidence and mortality data from WHI, FDA Actions.
-
A shift has occurred in recent years from viewing menopause as "a natural life event" experienced by women to "a condition that requires medical management."
-
Laboratory science has delineated convincing connections between vitamin D and immune system function, some of which have been borne out in clinical trials on the prevention and treatment of respiratory infections.
-
-
The incidence and significance of mitral valve prolapse (MVP) in patients with Marfan syndrome is poorly understood.
-
In this paper, Van der Werf and colleagues from the University of Groningen report the diagnostic yield of comprehensive cardiologic and genetic examinations in surviving relatives of sudden, unexplained death victims and in victims of cardiac arrest where the event occurred between the age of 1 and 50 years.
-
Although cardiac resynchronization therapy (CRT) is a class-I indication for the treatment of NYHA class III-IV patients with heart failure, few class-IV patients have been treated in the reported trials.